Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
ddhCTP: Precision Inhibition of RNA Virus Replication
2026-05-30
Harness ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) for targeted disruption of RNA virus replication in advanced antiviral research. This article delivers actionable workflows, troubleshooting strategies, and translational insights, equipping virology labs to accelerate drug development and mechanistic discovery with confidence.
-
Applied Use of 2-(4,5,6,7-tetrabromo...) as a Small Molecule
2026-05-29
Unlock new frontiers in protein phase separation research with the CK2 and ERK8 inhibitor, a versatile small molecule tool. Its high purity, stability, and specificity empower advanced workflows in kinase signaling and protein condensate studies, delivering reliable results for cutting-edge biochemical research.
-
Ertugliflozin (PF-04971729): Advanced Workflows in Diabetes
2026-05-29
Ertugliflozin (PF-04971729) stands out for its high selectivity and proven efficacy in both glycemic control and weight reduction, making it a powerful tool for diabetes and cardiometabolic research. This guide details applied workflows, protocol enhancements, and troubleshooting strategies to leverage Ertugliflozin for robust and reproducible results.
-
Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Researc
2026-05-28
Q-VD-OPh is a highly potent, irreversible pan-caspase inhibitor that enables precise modulation of caspase-mediated apoptosis in vitro and in vivo. Its nanomolar activity, brain permeability, and broad caspase target spectrum make it a premier tool for apoptosis research, cell viability optimization, and neurodegenerative disease modeling.
-
SGI-1027: DNA Methyltransferase Inhibitor for Cancer Epigene
2026-05-28
SGI-1027 stands out as a DNA methyltransferase inhibitor that enables precise modulation of gene expression in cancer research workflows. Its dual mechanism—competitive inhibition and DNMT1 degradation—empowers researchers to reactivate silenced tumor suppressor genes and model epigenetic therapy strategies with confidence.
-
GSK3 Inhibition as a Host-Directed Strategy Against Tubercul
2026-05-27
The referenced study identifies glycogen synthase kinase 3 (GSK3) inhibition as a promising host-directed approach to control intracellular Mycobacterium tuberculosis (Mtb) infection. By focusing on macrophage signaling pathways rather than targeting the pathogen directly, the research opens new avenues for combating tuberculosis, especially in the context of antimicrobial resistance.
-
BicD and MAP7 Synergistically Activate Drosophila Kinesin-1
2026-05-27
This study reveals that the adaptor protein BicD and the microtubule-associated protein MAP7 activate Drosophila kinesin-1 through complementary mechanisms, overcoming the motor’s auto-inhibited state. The findings clarify how these regulatory proteins interact to enhance processive transport, with implications for understanding bidirectional cargo trafficking in cells.
-
Ertugliflozin Mitigates Tau Pathology via Brain Insulin Modu
2026-05-26
The reference study demonstrates that Ertugliflozin, a selective SGLT2 inhibitor, alleviates cognitive impairment and reduces tau hyperphosphorylation in a rat model of Alzheimer's disease by restoring disrupted brain insulin signaling. These findings highlight a novel mechanistic link between SGLT2 inhibition and neuroprotection, expanding the therapeutic potential of Ertugliflozin beyond diabetes research.
-
Canagliflozin Hemihydrate: Research-Grade SGLT2 Inhibitor In
2026-05-26
Explore the advanced scientific principles and research applications of Canagliflozin hemihydrate, a high-purity SGLT2 inhibitor, with in-depth analysis of its assay specificity and protocol optimization. This article uniquely examines practical assay decisions in light of cutting-edge mTOR pathway screening technologies.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X): Actionable Gu
2026-05-25
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents unwanted proteolysis during protein extraction and sample preparation, especially for workflows where divalent cations must be preserved. It is suitable for Western blotting, co-immunoprecipitation, and phosphorylation-sensitive assays, but is not intended for protocols requiring metalloprotease inhibition via EDTA.
-
Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis
2026-05-25
This study defines a novel ferroptosis-related gene signature for prognostication in hepatocellular carcinoma (HCC) and identifies atorvastatin as a potential agent to induce ferroptosis in HCC cells. The findings provide both a validated bioinformatic tool for risk stratification and experimental evidence supporting HMG-CoA reductase inhibitors in ferroptosis-based therapy.
-
JC-1 Fluorescent Probe: Precision Mitochondrial Assays Unloc
2026-05-24
JC-1 empowers researchers to decode mitochondrial health with ratiometric, real-time precision, enabling robust apoptosis detection and cellular bioenergetics studies. This guide delivers optimized workflows, troubleshooting insights, and actionable protocol parameters to maximize JC-1’s translational impact across cancer and metabolic research.
-
Light and Brassinolide Independently Regulate Arabidopsis Ro
2026-05-23
This study demonstrates that light and brassinosteroids (BRs), including brassinolide, modulate Arabidopsis seedling root growth largely via independent pathways. The findings clarify that both endogenous and exogenous BRs act as suppressors of root elongation, regardless of light conditions, redefining the established understanding of BR-light signaling interplay in early plant development.
-
Brassinolide: Applied Protocols for Plant and Biomedical Res
2026-05-22
Brassinolide (24-Epibrassinolide) stands out as a dual-domain tool, optimizing both plant growth assays and translational cancer or diabetes workflows. This guide delivers actionable protocols, comparative insights, and troubleshooting strategies to help researchers leverage Brassinolide’s full potential.
-
Lipid Peroxidation (MDA) Assay Kit: Precision in Oxidative S
2026-05-22
The Lipid Peroxidation (MDA) Assay Kit delivers unmatched sensitivity and reproducibility for malondialdehyde quantification in diverse biological samples. Its dual-mode colorimetric and fluorescence detection streamlines workflows in oxidative stress and ferroptosis research, directly supporting translational studies on drug resistance mechanisms.